| Novartis AG. (4/1/19). "Press Release: AveXis Expands World-leading Gene Therapy Manufacturing Capacity with Purchase of Advanced Biologics Therapy Manufacturing Campus in Longmont, Colorado". Basel. |
2019-04-01 |
| Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. |
2019-04-01 |
| MorphoSys AG. (4/1/19). "Press Release: Dr. Sarah Fakih Joins MorphoSys as Head of Corporate Communications and Investor Relations". Planegg. |
2019-04-01 |
| Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. |
2019-04-01 |
| Evotec SE. (4/1/19). "Press Release: Evotec AG Completes Conversion into Evotec SE". Hamburg. |
2019-04-01 |
| Affimed N.V.. (4/1/19). "Press Release: Affimed Highlights AFM24 Innate Cell Engager Novel Mechanism of Action and Potential for the Treatment of EGFR-expressing Solid Tumors at the American Association for Cancer Research (AACR) 2019 Annual Meeting". He |
2019-04-01 |
| Illumina, Inc.. (3/29/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Germany". San Diego, CA. |
2019-03-29 |
| ProteoNic Biotechnology B.V.. (3/28/19). "Press Release: ProteoNic Biotechnology Licenses Protein Production Technology to Bayer". Leiden. |
2019-03-28 |
| Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. |
2019-03-28 |
| Qiagen N.V.. (3/28/19). "Press Release: Qiagen Launches Novel Liquid Biopsy Solutions and NGS Panels with Seamlessly Integrated Bioinformatics to Support Advances in Cancer Research". Germantown, MD & Hilden. |
2019-03-28 |
| Probiodrug AG. (3/28/19). "Press Release: Probiodrug Reports Full Year 2018 Financial Results". Halle (Saale). |
2019-03-28 |
| Indivumed GmbH. (3/28/19). "Press Release: Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services". Hamburg & Westminster, CO. |
2019-03-28 |
| Evotec AG. (3/28/19). "Press Release: Evotec AG Fiscal Year 2018 Results – Accelerated Growth and Strong Long-term Outlook". Hamburg. |
2019-03-28 |
| Selexis S.A.. (3/28/19). "Press Release: Selexis Bolsters Business Development Team to Support Expanding Base of Partners Relying on Its SUREtechnology to Advance Complex Biologics and Vaccines". Geneva. |
2019-03-28 |
| Sartorius AG. (3/28/19). "Press Release: Sartorius Supervisory Board Extends Appointment of Board Member Rainer Lehmann". Göttingen. |
2019-03-28 |
| Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin. |
2019-03-27 |
| Cytena GmbH. (3/26/19). "Press Release: EUR 3 Million in Series A for the Growth and Development of Cytena GmbH". |
2019-03-26 |
| Curetis N.V.. (3/26/19). "Press Release: Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero". Amsterdam & Holzgerlingen. |
2019-03-26 |
| Evotec AG. (3/26/19). "Press Release: Evotec and The Mark Foundation for Cancer Research Announce Strategic Collaboration in Immuno-oncology". Hamburg. |
2019-03-26 |
| Breath Therapeutics B.V.. (3/26/19). "Press Release: Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome". Munich & Menlo Park, CA. |
2019-03-26 |
| Tecan Group Ltd.. (3/22/19). "Press Release: Tecan to Vertically Integrate Supplier of Key Parts". Männedorf. |
2019-03-22 |
| AC Immune S.A.. (3/21/19). "Press Release: AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update". Lausanne. |
2019-03-21 |
| Forma Therapeutics, Inc.. (3/21/19). "Press Release: Forma Therapeutics Announces Frank D. Lee as Chief Executive Officer". Watertown, MA. |
2019-03-21 |
| Atlatl Innovation Cluster. (3/20/19). "Press Release: Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai". Shanghai. |
2019-03-20 |
| 4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. |
2019-03-20 |
| University of Frankfurt. (3/20/19). "Press Release: CRISPR/Cas Libraries Open New Avenues in Cancer Research". |
2019-03-20 |
| Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. |
2019-03-19 |
| Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. |
2019-03-19 |
| Affimed N.V.. (3/19/19). "Press Release: Affimed Announces Milestone Payment from Genentech and ROCK Platform Presentation at Innate Killer Summit 2019, Further Highlighting Leadership in Innate Immunity". Heidelberg. |
2019-03-19 |
| SilverSky LifeSciences GmbH. (3/18/19). "Press Release: DxPx – The First International Diagnostics Partnering Conference". Düsseldorf. |
2019-03-18 |
| Mologen AG. (3/18/19). "Press Release: Early Departure of CEO". Berlin. |
2019-03-18 |
| CARB-X. (3/14/19). "Press Release: Germany Joins CARB-X Partnership in the Fight against Deadly Drug-resistant Superbugs". Berlin. |
2019-03-14 |
| Bruker Corporation. (3/14/19). "Press Release: Bruker Announces Acquisition of Scientific Software Provider Arxspan". Billerica, MA. |
2019-03-14 |
| Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. |
2019-03-14 |
| Merck KGaA. (3/14/19). "Press Release: Merck Announces Collaboration with Iktos for Generative Artificial Intelligence (AI) Technology [Not intended for US, Canada and UK-based media]". Darmstadt. |
2019-03-14 |
| MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. |
2019-03-13 |
| iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. |
2019-03-12 |
| ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. |
2019-03-12 |
| BRAIN AG. (3/12/19). "Press Release: Global Beverage Company Has Joined the DOLCE Program. New Member Gains Access to DOLCE Sweet Solutions in the Field of Beverages". Zwingenberg, Potsdam & La Madeleine Cedex. |
2019-03-12 |
| Tecan Group Ltd.. (3/11/19). "Press Release: Tecan Reports Strong Second Half and a Very Successful Fiscal Year 2018". Männedorf. |
2019-03-11 |
| Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. |
2019-03-11 |
| Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden. |
2019-03-08 |
| H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. |
2019-03-08 |
| MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. |
2019-03-07 |
| Boehringer Ingelheim. (3/7/19). "Press Release: Novel Antibody Shows Potential to Transform Treatment of Rare Form of Psoriasis". Ingelheim. |
2019-03-07 |
| Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA. |
2019-03-06 |
| Sartorius AG. (3/5/19). "Press Release: Sartorius Stedim Biotech and Novasep to Develop Novel Systems for Membrane Chromatography". Göttingen. |
2019-03-05 |
| Eurofins Scientific. (3/5/19). "Press Release: Eurofins Delivers Solid FY 2018 Results with Revenues of EUR 3,781m (+27% yoy) and Adjusted EBITDA of EUR 720m (19.0% of revenues), in Line with Its Recently Upgraded Objectives". |
2019-03-05 |
| Merck KGaA. (3/5/19). "Press Release: Open Letter to Versum Shareholders from Merck". Darmstadt. |
2019-03-05 |
| Seventure Partners. (3/5/19). "Press Release: Health for Life Capital II, World Leading Microbiome-focused Fund Announces its First Close". Paris. |
2019-03-05 |
| Enzymicals AG. (3/4/19). "Press Release: abcr GmbH and Enzymicals AG Deepen the Cooperation". Greifswald & Karlsruhe. |
2019-03-04 |
| Merck KGaA. (3/4/19). "Press Release: Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. |
2019-03-04 |
| NovoGo Therapeutics AG. (3/4/19). "Press Release: NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke". Zurich. |
2019-03-04 |
| Neurimmune AG. (3/1/19). "Press Release: Neurimmune Appoints John Dellapa as General Counsel". Schlieren. |
2019-03-01 |
| UCB S.A.. (3/1/19). "Press Release: New Data Affirms Strength of UCB Immuno-Dermatology Portfolio". Brussels. |
2019-03-01 |
| Evotec AG. (2/28/19). "Press Release: Evotec Receives Milestone Payment for Start of Second Phase II Trial in Its Muli-target Alliance with Bayer". Hamburg. |
2019-02-28 |
| UCB S.A.. (2/28/19). "Press Release: UCB Full Year Report 2018. 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB’s Strong Pipeline". Brussels. |
2019-02-28 |
| Centogene AG. (2/28/19). "Press Release: Centogene Announces Strategic Collaboration with Sarepta Therapeutics". Rostock. |
2019-02-28 |
| iOnctura S.A.. (2/28/19). "Press Release: iOnctura Selected for an Oral Presentation at 2019 AACR Annual Meeting". Geneva. |
2019-02-28 |
| Aimmune Therapeutics, Inc.. (2/28/19). "Press Release: Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights". Brisbane, CA. |
2019-02-28 |
| MaRS Innovation. (2/27/19). "Press Release: MaRS Innovation Adds to Growing Portfolio with Two New LAB150 Projects to Create Novel Therapeutics for Cystic Fibrosis and Respiratory Syncytial Virus". Toronto, ON. |
2019-02-27 |
| CureVac AG. (2/27/19). "Press Release: CEPI Awards US$ 34m Contract to CureVac to Advance the RNA Printer—a Disruptive, Transportable mRNA Vaccine Manufacturing Platform that Can Rapidly Combat Multiple Diseases". Oslo. |
2019-02-27 |
| Merck KGaA. (2/27/19). "Press Release: Merck Submits All-Cash Proposal to Acquire Versum. $48 Per Share Proposal Represents a Premium to Current Value of Entegris’ All-Stock Proposal". Darmstadt. |
2019-02-27 |
| MorphoSys AG. (2/27/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received U.S. FDA Approval for Tremfya One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis". Planegg. |
2019-02-27 |
| Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". |
2019-02-26 |
| Hookipa Pharma Inc.. (2/26/19). "Press Release: Hookipa Pharma Raises $37.4 Million (€33.2 Million) in Series D Financing". New York, NY & Vienna. |
2019-02-26 |
| Samsara Therapeutics, Inc.. (2/26/19). "Press Release: Samsara Therapeutics Closes Seed Round Led by Apollo Ventures". New York, NY & Hamburg. |
2019-02-26 |
| Codexis, Inc.. (2/26/19). "Press Release: Codexis Reports 2018 Fourth Quarter and Full Year Financial Results". Redwood City, CA. |
2019-02-26 |
| Gain Therapeutics SA. (2/26/19). "Press Release: Gain Therapeutics SA Announces Award of Grant Support from Leading Parkinson’s Research Foundations to Advance Its Proprietary Non Competitive Molecular Chaperones for Parkinson’s Disease". Lugano & Barcel |
2019-02-26 |
| Anaveon AG. (2/26/19). "Press Release: Anaveon, a New Immuno-Oncology Company, Announces CHF 35 Million Series A Financing". Basel. |
2019-02-26 |
| Roche. (2/25/19). "Press Release: Roche Enters into Definitive Merger Agreement to Acquire Spark Therapeutics". Basel. |
2019-02-25 |
| Danaher Corporation. (2/25/19). "Press Release: Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion". Washington, DC. |
2019-02-25 |
| Medigene AG. (2/25/19). "Press Release: European Patent Covering TCR Library Suitable for the Development of Neoantigen-specific TCRs". Martinsried. |
2019-02-25 |
| Lonza Group AG. (2/25/19). "Press Release: Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment". Basel. |
2019-02-25 |
| CRISPR Therapeutics AG. (2/25/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results". Zug & Cambridge, MA. |
2019-02-25 |
| Boehringer Ingelheim. (2/25/19). "Press Release: New Chief Medical Officer Appointed". Ingelheim. |
2019-02-25 |
| Themis Bioscience GmbH. (2/25/19). "Press Release: Themis Bioscience Receives FDA Fast Track Designation for Chikungunya Vaccine Candidate". Vienna. |
2019-02-25 |
| Eppendorf AG. (2/21/19). "Press Release: Thomas Heydler Appointed to the Supervisory Board of Eppendorf AG". Hamburg. |
2019-02-21 |
| HeiScreen GmbH. (2/21/19). "Press Release: Researchers at Heidelberg University Hospital Develop First Marketable Blood Test for Breast Cancer". Düsseldorf & Heidelberg. |
2019-02-21 |
| Evotec AG. (2/20/19). "Press Release: Evotec and Helmholtz Centre Joining Platforms and Forces for Novel Antibiotics". Hamburg & Braunschweig. |
2019-02-20 |
| Calypso Biotech S.A.. (2/20/19). "Press Release: Calypso Biotech BV Secures 20 Million EUR in Series A Financing and Strengthens Team to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases". Amsterdam. |
2019-02-20 |
| BASF AG. (2/20/19). "Press Release: BASF’s Investment into Alchemist Accelerator Promotes Digital Innovations in the Chemical Industry". San Francisco, CA & Ludwigshafen. |
2019-02-20 |
| ADC Therapeutics S.A.. (2/20/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-402 (loncastuximab tesirine) and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma" |
2019-02-20 |
| MorphoSys AG. (2/19/19). "Press Release: Simon Moroney, CEO and Co-Founder of MorphoSys, Announces His Intention to Retire". Planegg. |
2019-02-19 |
| GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma". Basel. |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Personalised Medicine Entrectinib". Basel. |
2019-02-19 |
| CRISPR Therapeutics AG. (2/19/19). "Press Release: CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement". Zug, Cambridge, MA & Durham, NC. |
2019-02-19 |
| Nabriva Therapeutics plc. (2/19/19). "Press Release: Nabriva Therapeutics Announces Acceptance of New Drug Applications by the FDA for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. |
2019-02-19 |
| Merck KGaA. (2/19/19). "Press Release: Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method". Darmstadt. |
2019-02-19 |
| France Biotech. (2/19/19). "Press Release: France Biotech Announces Launch of HealthTech Investor Day in Paris on June 25th, 2019". Paris. |
2019-02-19 |
| Sartorius AG. (2/19/19). "Press Release: Sartorius Closes Fiscal 2018 Successfully and Aims to Further Expand". Göttingen. |
2019-02-19 |
| S-Biomedic N.V.. (2/18/19). "Press Release: Microbiome Pioneer S-Biomedic Completes Series A Round with DSM Venturing". Belgium. |
2019-02-18 |
| Curetis N.V.. (2/18/19). "Press Release: Curetis’ Subsidiary Ares Genetics and Qiagen Enter into Bioinformatics Partnership to Fight Antimicrobial Resistance". Vienna, Holzgerlingen & Amsterdam. |
2019-02-18 |
| Merck KGaA. (2/16/19). "Press Release: Pivotal Phase III Data for Bavencio (avelumab) plus Inlyta (axitinib) in Advanced Renal Cell Carcinoma Published in The New England Journal of Medicine [Not intended for US, Canada and UK-based media]". Darmstadt & |
2019-02-16 |
| Bayer AG / Bayer Corporation. (2/15/19). "Press Release: Bayer to Obtain Full Rights to Global Development and Commercialization of Oncology Compounds Vitrakvi (larotrectinib) and BAY 2731954 (LOXO-195)". Whippany, NJ. |
2019-02-15 |
| Hookipa Pharma Inc.. (2/15/19). "Press Release: Hookipa Appoints Michael A. Kelly as Independent Director". New York, NY & Vienna. |
2019-02-15 |
| InflaRx N.V.. (2/14/19). "Press Release: Richard Brudnick to Join InflaRx Board of Directors". Jena. |
2019-02-14 |
| High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". |
2019-02-14 |
| Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. |
2019-02-14 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 39 40 41 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
